News

The new funding follows the positive results demonstrated during the OLNORME (Occurrence of novel Ligands for a Nuclear Orphan Receptor in plant Metabolites) programme, initiated in 2006. During

The Scopius-5 database platform stores many details of selected compounds such as: multiple-conformation 3D models, shape and charge descriptors, property values and compound availability information, and/or synthetic route

In addition, 3M has IRMs available for license in the areas of cancer, asthma/allergy and as vaccine adjuvants. 3M Drug Delivery Systems Vaccine Business Development director Mark Tomai

Under the terms of the agreement, Recordati receives exclusive rights to develop and subsequently market and sell NX-1207 in Europe including Russia and the CIS, the Middle East,

NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus.Neuralstem president and CEO Richard Garr said that the commencement of

In November, the company reported that it had received a question from the FDA regarding chemistry, manufacturing and controls (CMC) that has now been resolved. Preclinical studies of

Under the terms of agreement, GSK will obtain an exclusive license to commercialize IPX066 throughout the world, except in the US and Taiwan. Impax will receive an upfront

Catalyst and Wyeth LLC (the successor to Wyeth), a wholly owned subsidiary of Pfizer, formed an exclusive, worldwide collaboration for the discovery, development and commercialization of improved, second

CombiPlex is an approach using drug carriers (nano-scale liposomes) to deliver synergistic ratios of drug combinations for the treatment of cancer. Celator Pharma claims that in contrast to